Kidney Stones Clinical Trial
Official title:
Can a Spot Urine Replace or Improve 24 Hour Urine Collections in Kidney Stone Patients
This study will sought to determine if limited urine collections can provide similar or more informative data than standard 24-hour urine collections used to evaluate kidney stone formers.
BACKGROUND Urinary stone disease is a common problem, causing significant morbidity and
sometimes mortality. Stone disease affects 5-10% of the population during their lifetime and
of these patients between 30-50% will have at least one recurrent episode.
Urinary stones arise due to crystallization and aggregation of supersaturated ion complexes
in the urine. Depending on the concentration of various urinary constituents and the
physicochemical characteristics of a given individual's urine (such as pH, volume, calcium
citrate concentration etc.), different crystals may precipitate. Therefore therapy is
tailored to the individual, based on stone composition and the results of the 24-hour urine
collection. The majority of the stones are calcium based (calcium oxalate, calcium
phosphate) while the remaining are comprised of uric acid, struvite, cystine or other
substances.
While some stones can pass spontaneously, the majority will require some form of treatment,
and more than 50% will require surgical intervention. Until the 1980s, treatment of upper
urinary tract stones often involved extensive open surgical procedures5. With the
introduction of extracorporeal shock-wave lithotripsy (ESWL) and refinements in
endourological procedures like percutaneous nephrolithotomy (PCNL), ureteroscopy (URS)
techniques, it has now become possible to treat stones in almost all cases without open
surgery. Stone management can be divided into three treatment phases. The first phase
involves treatment of acute pain and the drainage of an obstructed and possibly infected
kidney. The second phase aims to either remove or disintegrate the stone. The third phase is
directed towards the prophylaxis of stone recurrence .
The third phase involves the metabolic evaluation of the patient to identify possible risk
factors for forming recurrent stones, which consists of a 24 hour urine analysis to
determine the content of urinary components such as calcium or oxalate that play a major
role in stone disease. High levels of oxalate and calcium contribute to kidney stones
recurrences and therapy to reduce these two substances in the urine can reduce recurrence
rates. Low levels of citrate also increase the risk for forming stones, and can be treated
with alkali such as potassium citrate.
Collecting 24-hour urines for evaluation and therapy can be cumbersome for patients and
often leads to incorrect collection, which may be detectable by measuring the amount of
creatinine in each sample. Previous attempts to evaluate spot versus 24-hour urines have
been made, but more studies are necessary to determine how they compare to the conventional
24-hour collection. A more convenient method for collecting urine samples will facilitate
the treatment and future prevention of recurrent kidney stone disease.
The aim of this project is to determine whether spot urines collected separately at key
times throughout the day are comparable to the conventional pooled 24-hour urine collection,
and whether the former yield more accurate information in terms of the levels of urinary
components. Perhaps a patient with normal values for a pooled 24-hour collection may show
spikes in certain variables throughout the day that would not be discovered in the 24-hour
sample. Furthermore, reducing the collection to a single time point would improve patient
compliance making it easier to do subsequent follow-up collections.
HYPOTHESIS AND OBJECTIVES We hypothesize that spot urines can provide equivalent information
to that provided by a 24-hour urine test. An added benefit would be if spot urines provide
more information for the identification of risk factors in patients who have normal 24-hour
urine tests. A third possibility is that our hypothesis is incorrect and that a 24-hour
urine sample will provide the most useful data in formulating a stone prevention therapy for
our patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02547805 -
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
|
Phase 2 | |
Completed |
NCT02579161 -
Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy
|
Phase 3 | |
Completed |
NCT01187745 -
Study to Look for Artifact on Computed Tomography (CT) Representing Kidney Stones
|
N/A | |
Withdrawn |
NCT00875823 -
International Registry for Primary Hyperoxaluria
|
N/A | |
Completed |
NCT05519150 -
Donors With Nephrolithiasis at the Time of Transplant Evaluation (DONATE). Long Term Follow-up.
|
||
Recruiting |
NCT02522689 -
Comparison of Ultra-mini PCNL and Micro PCNL
|
N/A | |
Recruiting |
NCT01514032 -
Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones
|
N/A | |
Completed |
NCT00765128 -
Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy
|
Phase 4 | |
Completed |
NCT00873054 -
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
|
N/A | |
Withdrawn |
NCT00583258 -
A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones
|
N/A | |
Active, not recruiting |
NCT03630926 -
Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.
|
||
Not yet recruiting |
NCT02214836 -
Ultrasound Imaging of Kidney Stones and Lithotripsy
|
N/A | |
Completed |
NCT03095885 -
A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
|
N/A | |
Completed |
NCT01330940 -
Effect of Diet Orange Soda on Urinary Lithogenicity
|
N/A | |
Completed |
NCT01088555 -
Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers
|
N/A | |
Recruiting |
NCT00489723 -
Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?
|
N/A | |
Recruiting |
NCT05417568 -
Oxalate-Driven Host Responses in Kidney Stone Disease
|
N/A | |
Recruiting |
NCT02375295 -
Struvite Stones Antibiotic Study
|
Phase 4 | |
Enrolling by invitation |
NCT02408211 -
Preoperative Antibiotic PNL Study
|
Phase 4 | |
Withdrawn |
NCT01560091 -
Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy
|
Phase 3 |